Related Experiment Video
Updated: Mar 20, 2026

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
Published on: December 13, 2024
Pulmonary mycoses: a clinical perspective
Klara Verstappen1,2, Cédric Bosteels1,2, Eva Van Braeckel1,2
1Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Pulmonary mycoses are diverse fungal infections affecting the lungs. Early diagnosis and prompt treatment, utilizing advanced imaging and markers like beta-glucan, are crucial for managing these complex diseases.
Area of Science:
- Pulmonology and Mycology
- Infectious Diseases
- Immunology
Background:
- Pulmonary mycoses involve various fungi, with susceptibility linked to immune defects and barrier disruption.
- Clinical and radiological presentations are highly variable, necessitating accurate diagnostics.
Purpose of the Study:
- To review current knowledge on pulmonary mycoses.
- To highlight practical considerations for diagnosis and management.
Main Methods:
- Synthesis of current literature on epidemiology, clinical and radiological features.
- Review of diagnostic methods including imaging, histopathology, and biomarkers.
- Assessment of therapeutic options, including emerging agents and immunotherapy.
Main Results:
- Pulmonary mycoses present diversely, from colonization to life-threatening disease.
- High-resolution CT aids diagnosis, but histopathology remains gold standard.
- (1→3)-β-d-glucan and other markers guide diagnosis; culture-based and non-culture-based tests are essential for pathogen identification.
Conclusions:
- Prompt, guideline-concordant therapy is emphasized.
- Emerging antifungal agents and immunotherapies offer hope for resistant cases.
- Integrated diagnostic approaches are key for effective management of pulmonary fungal infections.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Fungal Group Zygomycota

